Please login to the form below
With Spiriva under pressure, Boehringer moves to bolster pipeline
Forges alliance with PureTech Health
Novartis makes case for gene therapy Zolgensma in SMA
New data revealed ahead of FDA review
Gilead drives NASH development with insitro collaboration
Announcement comes days after Novo Nordisk deal
Catalent preps for complex therapy boom with $1.2bn Paragon buy
Reflects growing investment in cell and gene therapies
First-in-class hepatitis B/D drug raises cure hope
Those taking the regimen saw virus levels decline
J&J’s Invokana first SGLT2 to show kidney disease benefits
Could help revival after amputation risk scare
Promethera’s liver failure stem cell therapy clears first hurdle
Technique could be alternative to transplant
CAR-T player Autolus seeks $100m from follow-on financing
Funds will further develop pipeline
Novo Nordisk and Gilead join forces in NASH
Will combine semaglutide with Gilead’s cilofexor and firsocostat
Adopting a creative IP approach towards biotech clusters
Why big pharma paradigm needs to change
-
A unique ecosystem How life science and healthcare clusters are driving innovation
-
Riding the wave of digital disruptionThe challenges and rewards of meeting consumer expectations
-
Intercept builds its case for Ocaliva in NASH, but safety still an issueMixed efficacy and safety results hits NASH frontrunner
-
Galderma launches Rosacea awareness campaignCampaign comes on the back of Rosacea Awareness Month
-
Voice biomarker device could diagnose depression, heart diseaseSonde Health raises $16m in series A round
-
Merck KGaA exec takes top job at UK biotech KymabUK biotech veteran returns to head antibody specialist
-
Alnylam swaps Sanofi for Regeneron as R&D partnerNovel alliance between two biotechs
-
Roche says ‘discovery proteomics’ is heading for clinical trialsTech has potential to identify novel biomarkers
-
Autolus’ next-gen CAR-T looks promising in ALLSafety profile could bring greater market potential
-
Lilly appoints Maura Dickler as VP of late phase oncology developmentShe will join the pharma firm from the Memorial Sloan Kettering Cancer Center
-
Metrion Biosciences establishes scientific advisory board
The board will provide scientific oversight and strategic advice to Metrion
-
Dr Sotirios Stergiopoulos leaves Shire for IpsenHe becomes the French biopharma’s chief medical officer
-
Linda Law joins Advicenne as US VP, clinical development and med affairsShe will oversee the biopharma’s developments with its dTRA candidate
-
Dr Fiona Marshall heads up MSD's new UK research facility She will be based in London and focus on early bioscience discovery
Latest research appointments
Featured jobs
- Project Manager - Medical Communications – South Wales
-
Excellent Remuneration Package
- Senior Account Manager- Pharma and Life Scienes
-
Competitive salary and benefits
-
Director – Healthcare PR
-
Salary TBC
- Account Manager / Senior Account Manager - Healthcare Advertisin...
-
Excellent Remuneration
- Project Manager - Digital Healthcare - London
-
Excellent Remuneration Package
- Experienced / Senior Account Director - Publications - London
-
Up to £80, 000 plus great benefits
- Science Writer, Healthcare Advertising Agency
-
£40, 000 - 45, 000 DOE benefits,
- Account Manager, Medical Communications and Marketing
-
£30, 000 – £40, 000 benefits and bonus
- Senior / Principal Medical Writer - MedComms - Home Based / Vari...
-
Excellent Remuneration Packages
- Freelance Medical Writer - Healthcare Advertising - London
-
Employment Type:. Type of Job:. Region:. Salary:. 250 to 330 per day
-
Senior Medical Writer
-
Competitive salary and benefits
- Editor – Medical Education Agency – Bucks
-
Salary TBC
- Account Director – London based Medical Communications Agency
-
Excellent Remuneration Package
- Senior Account Director/ Associate Director- Pharma and Life Sci...
-
Competitive salary and benefits
-
Account Director, Medical Education
-
Salary TBC
-
Senior Medical Writer
-
Salary TBC
Subscribe to our email news alerts
- With Spiriva under pressure, Boehringer moves to bolster pipeline
- Genfit claims FDA breakthrough status for liver disease drug
- Mereo’s shareholders back OncoMed takeover
- Lucid Group announces the appointment of new CFO
- From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
- Q&A: Niels Lund
PMHub
Synergy Vision
Synergy Vision believe in delivering medical communications that make a difference to healthcare professionals and patients. Our synergy of pharma...
Latest intelligence
- From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
- How pharma is progressing their commitment in patient engagement...
- Cuttsy+Cuttsy awarded CPD Platinum by the IPA
- Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
- Breaking Bad
- Six behaviours separate the good brand teams from the bad...
Quick links
Infographics
